H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 675,647. Massachusetts Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Boston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Boston storefront.
Biologic Solutions for Chronic Wounds in Boston, MA for clinics & physicians. Biologic solutions for chron… Compliance support & pricing — contact Hawk Medical.
6.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Population 675,647. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JK documentation are ready before the first application of biologic solutions chronic wounds.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)6.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 500k–1M with 675,647 residents will still mix those payers. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the biologic solutions chronic wounds account.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 23.4%; arthritis is 17.8%. That is place-level BRFSS modeling, not a clinic census and not a Boston trial.
Massachusetts is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Massachusetts.
Massachusetts is in CMS MAC JK, administered by National Government Services (NGS). CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Boston, MA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Boston is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Boston — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Massachusetts Part B wound biologics follow this contractor (siblings: CT, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Boston. Useful for joint-program math; still needs a diagnosis and privileging.
No Boston storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.